Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0283 | 0.2887 | 0.7993 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0107 | 0.0256 | 0.0178 |
Giardia lamblia | Phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.0213 | 0.1851 | 1 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0328 | 0.3562 | 1 |
Trichomonas vaginalis | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Toxoplasma gondii | Purine nucleoside phosphorylase | 0.0107 | 0.0256 | 0.5 |
Treponema pallidum | purine nucleoside phosphorylase (deoD) | 0.0107 | 0.0256 | 0.5 |
Mycobacterium ulcerans | purine nucleoside phosphorylase | 0.0107 | 0.0256 | 0.5 |
Echinococcus granulosus | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0172 | 0.1232 | 0.1002 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0259 | 0.2526 | 0.6923 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0259 | 0.2526 | 0.6923 |
Toxoplasma gondii | phosphorylase family protein | 0.0107 | 0.0256 | 0.5 |
Schistosoma mansoni | purine nucleoside phosphorylase | 0.0107 | 0.0256 | 0.0061 |
Mycobacterium tuberculosis | Probable purine nucleoside phosphorylase DeoD (inosine phosphorylase) (PNP) | 0.0107 | 0.0256 | 0.5 |
Loa Loa (eye worm) | S-methyl-5'-thioadenosine phosphorylase MTAP | 0.0107 | 0.0256 | 0.0256 |
Mycobacterium leprae | probable uridine phosphorylase | 0.0758 | 1 | 1 |
Trypanosoma cruzi | nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0718 |
Echinococcus multilocularis | uridine phosphorylase 1 | 0.0758 | 1 | 1 |
Chlamydia trachomatis | AMP nucleosidase | 0.0107 | 0.0256 | 0.5 |
Trypanosoma cruzi | methylthioadenosine phosphorylase, putative | 0.0107 | 0.0256 | 0.0718 |
Leishmania major | methylthioadenosine phosphorylase, putative | 0.0107 | 0.0256 | 0.5 |
Mycobacterium tuberculosis | Probable bifunctional MTA/SAH nucleosidase Mtn: 5'-methylthioadenosine nucleosidase (methylthioadenosine methylthioribohydrolase | 0.0107 | 0.0256 | 0.5 |
Plasmodium vivax | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.5 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0328 | 0.3562 | 0.3433 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0172 | 0.1232 | 0.1056 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0328 | 0.3562 | 1 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Trichomonas vaginalis | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Treponema pallidum | uridine phosphorylase (udp) | 0.0107 | 0.0256 | 0.5 |
Leishmania major | nucleoside phosphorylase-like protein | 0.0107 | 0.0256 | 0.5 |
Onchocerca volvulus | Purine nucleoside phosphorylase homolog | 0.0107 | 0.0256 | 0.5 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0328 | 0.3562 | 1 |
Schistosoma mansoni | methylthioadenosine phosphorylase | 0.0107 | 0.0256 | 0.0061 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0127 | 0.0556 | 0.107 |
Entamoeba histolytica | MTA/SAH nucleosidase, putative | 0.0107 | 0.0256 | 0.0178 |
Trypanosoma cruzi | nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0718 |
Plasmodium falciparum | purine nucleoside phosphorylase | 0.0107 | 0.0256 | 0.5 |
Mycobacterium ulcerans | 5'-methylthioadenosine phosphorylase | 0.0107 | 0.0256 | 0.5 |
Schistosoma mansoni | methylthioadenosine phosphorylase | 0.0107 | 0.0256 | 0.0061 |
Trypanosoma brucei | uridine phosphorylase | 0.0107 | 0.0256 | 1 |
Trichomonas vaginalis | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Mycobacterium ulcerans | bifunctional Mta/Sah nucleosidase Mtn | 0.0107 | 0.0256 | 0.5 |
Echinococcus granulosus | uridine phosphorylase 1 | 0.0758 | 1 | 1 |
Trichomonas vaginalis | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Treponema pallidum | pfs protein (pfs) | 0.0107 | 0.0256 | 0.5 |
Trichomonas vaginalis | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Brugia malayi | phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative | 0.0195 | 0.1572 | 0.1403 |
Schistosoma mansoni | uridine phosphorylase | 0.0758 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0107 | 0.0256 | 0.0178 |
Trypanosoma cruzi | nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0718 |
Entamoeba histolytica | hypothetical protein | 0.0107 | 0.0256 | 0.0178 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Trypanosoma brucei | methylthioadenosine phosphorylase, putative | 0.0107 | 0.0256 | 1 |
Schistosoma mansoni | uridine phosphorylase | 0.0758 | 1 | 1 |
Loa Loa (eye worm) | uridine phosphorylase | 0.0758 | 1 | 1 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0523 | 0.6475 | 0.6405 |
Brugia malayi | purine nucleoside phosphorylase I, inosine and guanosine-specific family protein | 0.0107 | 0.0256 | 0.0061 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.0989 | 0.0989 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0328 | 0.3562 | 1 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0328 | 0.3562 | 1 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.0523 | 0.6475 | 0.6383 |
Trichomonas vaginalis | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Toxoplasma gondii | phosphorylase family protein | 0.0107 | 0.0256 | 0.5 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0523 | 0.6475 | 0.6383 |
Echinococcus multilocularis | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0172 | 0.1232 | 0.1002 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0328 | 0.3562 | 1 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0107 | 0.0256 | 0.5 |
Brugia malayi | MTAP | 0.0107 | 0.0256 | 0.0061 |
Trypanosoma cruzi | methylthioadenosine phosphorylase, putative | 0.0107 | 0.0256 | 0.0718 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase vps34-like | 0.0103 | 0.0196 | 0.055 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0107 | 0.0256 | 0.5 |
Schistosoma mansoni | methylthioadenosine phosphorylase | 0.0107 | 0.0256 | 0.0061 |
Trichomonas vaginalis | purine nucleoside phosphorylase I, putative | 0.0107 | 0.0256 | 0.0178 |
Trichomonas vaginalis | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Entamoeba histolytica | hypothetical protein | 0.0283 | 0.2887 | 0.7993 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0107 | 0.0256 | 0.0178 |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.0315 | 0.3366 | 0.9418 |
Schistosoma mansoni | purine nucleoside phosphorylase | 0.0107 | 0.0256 | 0.0061 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0478 | 0.58 | 0.58 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.1232 | 0.1232 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.01 uM | Inhibitory activity against wild type HIV-1 LAI cell line | ChEMBL. | 15481987 |
IC50 (functional) | = 0.31 uM | Inhibitory activity against HIV-1 mutant strain 103N | ChEMBL. | 15481987 |
IC50 (functional) | = 100 uM | Inhibitory activity against HIV-1 mutant strain 188L | ChEMBL. | 15481987 |
IC50 (functional) | = 3981 uM | Inhibitory activity against HIV-1 mutant strain 181C | ChEMBL. | 15481987 |
Selectivity index (functional) | = 6310 uM | Selectivity index of cytotoxic activity (CC50) to inhibitory activity (IC50) relative to LAI cell line | ChEMBL. | 15481987 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.